Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The trust was successful in obtaining a grant from NIHR for a clinical trial to look at the use of metformin in people newly diagnosed with psychosis. The clinical trial (including the recruitment phase) is estimated to take place between June 2026 to November 2028. As part of that grant we need to source a supplier that has the capability to purchase or manufacture Metformin and an identical placebo for a clinical trial, to package and label both to our requirements and distribute to Trusts across the UK in a predetermined schedule
| Supplier | Identifier | Award Value | Lots Won | Cross-References |
|---|---|---|---|---|
| Calderdale and Huddersfield NHS Foundation Trust trading as "Huddersfield Pharmacy Specials" | Procurement ID: PNNL-2286-HTYH | £248,333 | 1 lot Lot 1 | - |
This procurement was divided into 1 lots, each awarded separately. 4 bids were received in total.
| Lot | Value | Bids Received | Awarded To | Status |
|---|---|---|---|---|
| Lot 1 Oct 2025 – Oct 2028 | £248,333 £250,114 initial term | 4 | Calderdale and Huddersfield NHS Foundation Trust trading as "Huddersfield Pharmacy Specials" | active |
Weightings from the notice.
Changes the buyer published to this notice after it first appeared.
Incorrect Project Title